Psychedelic-Assisted Psychotherapy: When Two Traditions Meet
European Psychiatry June 1, 2022 E. Frecska, A. Kazai, P. Bokor et al.
Introduction After a long moratorium since the Controlled Substances Act was passed in 1970, there has been a resurgence of research on the potential therapeutic benefits of psychedelic (PE) compounds. It has been widely believed that the PE effect is a result of the interaction between the drug and the mindset of the patient (the “set”) with the external physical and social conditions (the...